Heart failure in the elderly

被引:47
作者
Diez-Villanueva, Pablo [1 ]
Jimenez-Mendez, Cesar [1 ]
Alfonso, Fernando [1 ]
机构
[1] Univ Autonoma Madrid, Hosp Univ La Princesa, Cardiol Dept, CIBER CV, Madrid, Spain
关键词
CARDIAC RESYNCHRONIZATION THERAPY; PRESERVED EJECTION FRACTION; BRAIN NATRIURETIC PEPTIDE; VENTRICULAR ASSIST DEVICE; OLDER PATIENTS; FERRIC CARBOXYMALTOSE; PALLIATIVE CARE; MEDICAL THERAPY; AGE INSIGHTS; TASK-FORCE;
D O I
10.11909/j.issn.1671-5411.2021.03.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) is a clinical syndrome caused by structural and/or functional cardiac abnormalities, resulting in a reduced cardiac output and/or elevated intracardiac filling pressures at rest or during stress. HF is a major public health problem with high prevalence and incidence, involving both high morbidity and mortality, but also high economic costs. The incidence of HF progressively increases with age, reaching around 20% among people over 75 years old. Indeed, HF represents the leading cause of hospitalization in patients older than 65 years in Western countries. Hence, some authors even consider HF a geriatric syndrome, entailing worse prognosis and high residual disability, and often associating some complex comorbidities, common in older population, that may further complicate the course of the disease. On the other hand, however, clinical course and prognosis may be often difficult to predict. In this article, main pathophysiological issues related to the aging heart are addressed, together with key aspects related to both diagnosis and prognosis in elderly patients with HF. Besides, main geriatric conditions, common in the elderly population, are reviewed, highlighting the importance of a comprehensive and multidisciplinary approach.
引用
收藏
页码:219 / 232
页数:14
相关论文
共 105 条
[1]   Heart failure in older people: causes, diagnosis and treatment [J].
Abdelhafiz, AH .
AGE AND AGEING, 2002, 31 (01) :29-36
[2]   Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction [J].
Adamson, Philip B. ;
Abraham, William T. ;
Bourge, Robert C. ;
Costanzo, Maria Rosa ;
Hasan, Ayesha ;
Yadav, Chethan ;
Henderson, John ;
Cowart, Pam ;
Stevenson, Lynne Warner .
CIRCULATION-HEART FAILURE, 2014, 7 (06) :935-944
[3]   Evaluating and Treating Frailty in Cardiac Rehabilitation [J].
Afilalo, Jonathan .
CLINICS IN GERIATRIC MEDICINE, 2019, 35 (04) :445-+
[4]   Current use of guideline-based medical therapy in elderly patients admitted with acute heart failure with reduced ejection fraction and its impact on event-free survival [J].
Akita, Keitaro ;
Kohno, Takashi ;
Kohsaka, Shun ;
Shiraishi, Yasuyuki ;
Nagatomo, Yuji ;
Izumi, Yuki ;
Goda, Ayumi ;
Mizuno, Atsushi ;
Sawano, Mitsuaki ;
Inohara, Taku ;
Fukuda, Keiichi ;
Yoshikawa, Tsutomu .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 235 :162-168
[5]   β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure [J].
Ambrosio, Giuseppe ;
Flather, Marcus D. ;
Boehm, Michael ;
Cohen-Solal, Alain ;
Murrone, Adriano ;
Mascagni, Flavio ;
Spinucci, Giulio ;
Conti, Maria Giovanna ;
van Veldhuisen, Dirk J. ;
Tavazzi, Luigi ;
Coats, Andrew J. S. .
HEART, 2011, 97 (03) :209-214
[6]   Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. [J].
Anker, Stefan D. ;
Comin Colet, Josep ;
Filippatos, Gerasimos ;
Willenheimer, Ronnie ;
Dickstein, Kenneth ;
Drexler, Helmut ;
Luescher, Thomas F. ;
Bart, Boris ;
Banasiak, Waldemar ;
Niegowska, Joanna ;
Kirwan, Bridget-Anne ;
Mori, Claudio ;
Rothe, Barbara von Eisenhart ;
Pocock, Stuart J. ;
Poole-Wilson, Philip A. ;
Ponikowski, Piotr .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) :2436-2448
[7]   Ventricular Assist Device Implant in the Elderly Is Associated With Increased, but Respectable Risk: A Multi-Institutional Study [J].
Atluri, Pavan ;
Goldstone, Andrew B. ;
Kobrin, Dale M. ;
Cohen, Jeffrey E. ;
MacArthur, John W. ;
Howard, Jessica L. ;
Jessup, Mariell L. ;
Rame, J. Eduardo ;
Acker, Michael A. ;
Woo, Y. Joseph .
ANNALS OF THORACIC SURGERY, 2013, 96 (01) :141-147
[8]  
Azad N, 2014, J GERIATR CARDIOL, V11, P329, DOI 10.11909/j.issn.1671-5411.2014.04.008
[9]   Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT) [J].
Baruch, L ;
Glazer, RD ;
Aknay, N ;
Vanhaecke, J ;
Heywood, JT ;
Anand, I ;
Phil, D ;
Krum, H ;
Hester, A ;
Cohn, JN .
AMERICAN HEART JOURNAL, 2004, 148 (06) :951-957
[10]   Does the target dose of neurohormonal blockade matter for outcome in Systolic heart failure in octogenarians? [J].
Barywani, Salim Bary ;
Ergatoudes, Constantinos ;
Schaufelberger, Maria ;
Petzold, Max ;
Fu, Michael L. X. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 187 :666-672